| |
|
Form Serial No: |
CS20131007000276 |
| 1.
Name of listed corporation: |
China Animal Healthcare Ltd. |
| 2.
Stock code: |
00940 |
| 3.
Class of shares: |
Ordinary Shares |
| 4.
Number of issued shares in class: |
1,965,989,853 |
| 5.
Name of substantial shareholder: |
Eli Lilly and Company |
| 6.
Registered office: |
Lilly Corporate Center, Indianapolis, Indiana 46285, USA |
| 7.
Principal place of business in Hong Kong: |
N/A |
| 13.
Exchange on which listed: |
New York Stock Exchange |
| 14.
Name of listed parent and exchange on which parent is listed: |
N/A |
| 15.
Date of relevant event: |
04/10/2013
(dd/mm/yyyy)
|
| 16.
Date when the substantial shareholder became aware of the relevant event/ interest in the shares (if later): |
|
|
| 17.
Details of relevant event: |
|
|
Relevant event code describing circumstances
|
Code describing capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price per share
|
Average price per share
|
Average consideration per share
|
Consideration code
|
|
Long position |
104 |
205 |
205 |
240,860,938 |
SGD |
0.000 |
0.000 |
0.000 |
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long Position | 640,860,938 | 42.36 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long Position | 400,000,000 | 20.35 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Code describing capacity | Number of shares |
| 205 | |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Code describing derivatives | Number of shares |
| Nil | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling shareholder | % control | Direct interest | Number of shares |
| Eli Lilly International Corporation | Lilly Corporate Center, Indianapolis, Indiana, USA (Indiana, USA) | Eli Lilly and Company | 99.00 | Y | |
| Lilly Nederland Holding B.V. | Grootslag 1-5, 3991 RA Houten, Netherlands (Nethderlands) | Eli Lilly International Corporation | 100.00 | Y | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| Nil | | |
|
|
| 24.
Further information from a trustee, or beneficiary of a trust, or a founder of a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| Nil | | | |
|
|
| 25.
Further information from a party to an agreement under Section 317: |
| Names of other parties | Address | Number of shares |
| Nil | | |
| Total number of shares in which substantial shareholder is interested under section 317 and 318: |
|
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | % |
| Nil | | | |
|
| |
| 27.
Date of filing this Form 2: |
07/10/2013
(dd/mm/yyyy)
|
| 29.
Number of attachments: |
0 |
|
|
|
|